Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of GBP 82.49 billion. The enterprise value is 95.32 billion.

Market Cap	82.49B
Enterprise Value	95.32B

Important Dates

The last earnings date was Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	May 12, 2025

Share Statistics

Current Share Class	1.21B
Shares Outstanding	n/a
Shares Change (YoY)	-2.73%
Shares Change (QoQ)	-0.70%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	47.34%
Float	1.09B

Valuation Ratios

The trailing PE ratio is 12.50 and the forward PE ratio is 9.24.

PE Ratio	12.50
Forward PE	9.24
PS Ratio	2.00
PB Ratio	1.29
P/TBV Ratio	25.38
P/FCF Ratio	11.01
P/OCF Ratio	9.14
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.53, with an EV/FCF ratio of 12.73.

EV / Earnings	14.45
EV / Sales	2.32
EV / EBITDA	8.53
EV / EBIT	11.57
EV / FCF	12.73

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.27.

Current Ratio	1.01
Quick Ratio	0.20
Debt / Equity	0.27
Debt / EBITDA	1.53
Debt / FCF	2.33
Interest Coverage	18.84

Financial Efficiency

Return on equity (ROE) is 6.43% and return on invested capital (ROIC) is 9.38%.

Return on Equity (ROE)	6.43%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.38%
Return on Capital Employed (ROCE)	9.90%
Weighted Average Cost of Capital (WACC)	5.33%
Revenue Per Employee	552,446
Profits Per Employee	88,139
Employee Count	74,846
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Sanofi has paid 857.46 million in taxes.

Income Tax	857.46M
Effective Tax Rate	16.83%

Stock Price Statistics

The stock price has decreased by -13.76% in the last 52 weeks. The beta is 0.32, so Sanofi's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-13.76%
50-Day Moving Average	79.62
200-Day Moving Average	82.42
Relative Strength Index (RSI)	46.91
Average Volume (20 Days)	1,762,073

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of GBP 41.35 billion and earned 6.60 billion in profits. Earnings per share was 5.42.

Revenue	41.35B
Gross Profit	29.92B
Operating Income	8.47B
Pretax Income	5.09B
Net Income	6.60B
EBITDA	11.20B
EBIT	8.47B
Earnings Per Share (EPS)	5.42

Balance Sheet

The company has 4.84 billion in cash and 17.48 billion in debt, giving a net cash position of -12.64 billion.

Cash & Cash Equivalents	4.84B
Total Debt	17.48B
Net Cash	-12.64B
Net Cash Per Share	n/a
Equity (Book Value)	63.87B
Book Value Per Share	52.79
Working Capital	136.22M

Cash Flow

In the last 12 months, operating cash flow was 9.03 billion and capital expenditures -1.54 billion, giving a free cash flow of 7.49 billion.

Operating Cash Flow	9.03B
Capital Expenditures	-1.54B
Depreciation & Amortization	2.71B
Net Borrowing	1.30B
Free Cash Flow	7.49B
FCF Per Share	n/a

Margins

Gross margin is 72.36%, with operating and profit margins of 20.49% and 15.95%.

Gross Margin	72.36%
Operating Margin	20.49%
Pretax Margin	12.32%
Profit Margin	15.95%
EBITDA Margin	27.09%
EBIT Margin	20.49%
FCF Margin	18.11%

Dividends & Yields

This stock pays an annual dividend of 3.30, which amounts to a dividend yield of 4.14%.

Dividend Per Share	3.30
Dividend Yield	4.14%
Dividend Growth (YoY)	2.06%
Years of Dividend Growth	2
Payout Ratio	63.16%
Buyback Yield	2.73%
Shareholder Yield	6.87%
Earnings Yield	8.00%
FCF Yield	9.08%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4